Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway.

Area of Science:

• Biochemistry
• Cell Biology
• Toxicology

Background:

• Unconjugated bilirubin (UCB) is a heme catabolism product with known biological effects, including inhibition of cancer cell proliferation and toxicity to neurons and glial cells.
• The precise molecular mechanisms underlying UCB-induced cytotoxicity are not fully understood.
• Investigating early molecular events is crucial for understanding UCB's biological impact.

Purpose of the Study:

• To elucidate the early molecular events responsible for unconjugated bilirubin-induced cytotoxicity.
• To identify the signaling pathway modulated by UCB in cellular models.
• To understand the role of oxidative stress in UCB's cytotoxic effects.

Main Methods:

• Utilized HeLa cells and mouse embryonic fibroblasts exposed to specific concentrations of unconjugated bilirubin (UCB).
• Assessed cell survival using the MTT assay and measured intracellular reactive oxygen species (ROS) levels.
• Investigated the roles of APE1/Ref-1, Egr-1, and PTEN through gene silencing, promoter mutation studies, and antioxidant pretreatment (N-acetylcysteine).

Main Results:

• UCB induced significant oxidative stress, increasing ROS levels and decreasing cell survival.
• ROS activation led to the upregulation of APE1/Ref-1, Egr-1, and the tumor suppressor PTEN, inhibiting cell growth.
• Pretreatment with N-acetylcysteine to block ROS generation restored cell survival and prevented PTEN upregulation and proliferation inhibition.
• Experimental manipulations confirmed UCB's modulation of the APE1/Ref-1/Egr-1/PTEN signaling pathway.

Conclusions:

• UCB cytotoxicity is mediated by a novel signaling pathway involving oxidative stress, APE1/Ref-1, Egr-1, and PTEN.
• This pathway leads to the upregulation of PTEN, resulting in cell growth inhibition.
• Targeting oxidative stress or components of this pathway may offer therapeutic strategies against UCB toxicity.